Related Experiment Video
Updated: Aug 14, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Recent advances in the treatment of bladder cancer
Eric S Gwynn1, Peter E Clark, M Craig Hall
1Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. egwynn@wfubmc.edu
Abstract:
Bladder cancer continues to provide urologists and researchers with a clinical and scientific challenge. Several urinary markers used in the detection and screening of patients with bladder cancer are currently under investigation. Improvements in intravesical therapy are proving to help decrease both tumor recurrence and progression in patients with high-risk disease. In patients with organ-confined, node-negative bladder cancer, radical cystectomy provides excellent local control and long-term disease-free survival. The use of an extended lymphadenectomy at the time of cystectomy may yield improved prognostic information as well as a potential survival benefit. Neoadjuvant chemotherapy and less toxic combination chemotherapy regimens are offering potential improvements in patients with extravesical or nodal extension. The current methods of detection, as well as available therapeutic treatment options are reviewed.
Insights
Bladder cancer detection and treatment remain challenging. Research focuses on new urinary markers, improved intravesical therapies, and surgical/chemotherapy options to reduce recurrence and improve survival.
Area of Science:
- Urology
- Oncology
Background:
- Bladder cancer presents ongoing clinical and scientific challenges.
- Investigating novel urinary markers for early detection and screening is crucial.
- Advancements in intravesical therapy aim to reduce recurrence and progression in high-risk bladder cancer patients.
Purpose of the Study:
- To review current bladder cancer detection methods.
- To discuss available and emerging therapeutic treatment options.
- To highlight advancements in managing bladder cancer.
Main Methods:
- Review of current literature on bladder cancer detection.
- Analysis of intravesical therapy improvements.
- Evaluation of surgical interventions like radical cystectomy and extended lymphadenectomy.
- Assessment of neoadjuvant chemotherapy and novel chemotherapy regimens.
Main Results:
- Radical cystectomy offers excellent local control and survival for organ-confined, node-negative bladder cancer.
- Extended lymphadenectomy may improve prognostic information and survival.
- Neoadjuvant chemotherapy and less toxic regimens show promise for advanced bladder cancer.
- New urinary markers are under investigation for detection and screening.
Conclusions:
- Ongoing research into urinary markers and therapeutic strategies is vital for improving bladder cancer outcomes.
- Surgical and chemotherapeutic advancements offer better management for various stages of bladder cancer.
- A comprehensive approach combining detection, surgery, and chemotherapy is key to combating bladder cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers